Live chat at 12 p.m. ET: last week in CRISPR — cancer, patents, and a dip in the market

Join STAT's senior science writer, Sharon Begley, for an online chat about the latest developments with the genome-editing technology CRISPR. She'll take your questions about two new studies raising concerns…

More From BioPortfolio on "Live chat at 12 p.m. ET: last week in CRISPR — cancer, patents, and a dip in the market"